Rapid HIV test sales soar after US recommendation
This article was originally published in Clinica
Executive Summary
US sales of rapid HIV tests have soared in the wake of recent guidelines from the US Centers for Disease Control and Prevention (CDC). International Murex Technologies said sales of its SUDS HIV test increased 62% in March to more than $500,000.